Vanguard L4 Leptospira Vaccine
فانجارد إل 4 لقاح بكتين ليبتوسبيرا الرباعي للكلاب
Vanguard L4 is an inactivated liquid bacterin containing whole cell cultures of Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona. Indicated for the vaccination of healthy dogs 6 weeks of age or older as an aid in preventing leptospirosis, mortality, and urinary shedding caused by the four prevalent Leptospira serovars.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Boxes of 25 x 1-dose vials (1 mL each)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 1 mL administered subcutaneously | Subcutaneous (SC) | Initial 2-dose series administered 3 to 4 weeks apart; revaccinate annually |
Withdrawal Periods
No withdrawal information available.
Indications
-
Prevention of leptospirosis, clinical disease, mortality, and persistent urinary shedding in dogs caused by Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona.
Contraindications
-
Do not vaccinate clinically ill dogs.
Precautions
-
Anaphylactoid reactions can occur; administer epinephrine immediately if required.
Side Effects
-
Transient local soreness, mild bump at the injection site, or slight lethargy.
Images
Documents
-
Download
Vanguard L4 Leptospira Vaccine Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.